Imaging Technology

JANUARY 8, 2024

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Healthcare 91

Healthcare Healthcare Radiation Oncology Radiation 91

Imaging Technology

JUNE 12, 2023

The study findings appear online today in JAMA Oncology. “Postoperative SRS is currently the standard of care in these patients, but there is a growing body of research that shows preoperative SRS has advantages,” said Roshan Prabhu, M.D. , The two-year cavity local recurrence rate was 13.7%.

Radiation 87

Radiation Disease Radiation Oncology Ultrasound 87

Imaging Technology

APRIL 2, 2024

The availability of these offerings – including the MIM SurePlan and MIM Symphony families, MIM Maestro, MIM Encore, and more – is in alignment with GE HealthCare’s precision care strategy, which aims to deliver innovative digital solutions across care pathways for more precise, connected, and efficient care across disease states. "We

Healthcare 95

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 95

Imaging Technology

OCTOBER 2, 2023

Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting. Earlier detection allows for earlier treatment of residual disease and potentially better survival rates. and an estimated 4,000 Americans die from the disease each year. However, the tests are not yet widely available.

Disease 52

Disease Radiation Oncology Radiation Diagnose 52

Imaging Technology

APRIL 5, 2024

and around the world, with many promising drugs in clinical trials. The generator offers a low-cost alternative for the radiolabeling of biomolecules with Gallium-68 in PET, an imaging examination method used to detect the presence or absence of diseased tissue. The demand for radiopharmaceuticals continues to grow in the U.S.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

Imaging Technology

OCTOBER 3, 2023

2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA. We could not have achieved these interim clinical results without the support of the doctors and patients who were part of this registry study from across the nation," said Brachman.

Radiation Oncology 107

Radiation Oncology Radiation Medical Device Diagnose 107

Imaging Technology

OCTOBER 5, 2023

At the meeting, held from October 1 to October 4, 2023, in San Diego, Simon Powell, MD, PhD, FRCP , Chair of MSK’s Department of Radiation Oncology and Enid A. Haupt Chair in Radiation Oncology, was honored with ASTRO’s Gold Medal Award. It is caused by an inherited mutation in the gene TP53.

Radiation Oncology 52

Radiation Oncology Insurance Radiation Clinic 52

Imaging Technology

SEPTEMBER 27, 2023

milla1cf Wed, 09/27/2023 - 15:07 September 27, 2023 — The American Society for Radiation Oncology ( ASTRO ) announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge.

Radiation 94

Radiation Radiation Oncology Clinic Disease 94

Imaging Technology

OCTOBER 2, 2023

milla1cf Mon, 10/02/2023 - 13:30 October 2, 2023 — A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation, rather than drug-based therapy, a new study suggests. and worldwide. and worldwide. Chaudhuri explained.

Radiation 52

Radiation Radiation Oncology Disease Diagnose 52

AuntMinnie

APRIL 4, 2024

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. Morris specializes in prostate cancer and new investigational agents. When, in 2022, the U.S.

Nuclear Medicine 86

Nuclear Medicine Radiation Oncology Nursing Radiation 86

Imaging Technology

OCTOBER 1, 2023

Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting. have disparately worse clinical outcomes compared to other racial groups,” said lead study author Alexander J. Allen, MD , a radiation oncology resident physician at the University of Maryland Medical Center in Baltimore.

Radiation Oncology 82

Radiation Oncology Radiation Disease Medicare 82

Imaging Technology

SEPTEMBER 29, 2023

The findings, which are the latest from a series of studies investigating the benefits of stereotactic body radiation therapy (SBRT) for people diagnosed with prostate cancer, will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Radiation 84

Radiation Radiation Oncology Disease Diagnose 84

Imaging Technology

SEPTEMBER 27, 2023

PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. Clinical correlation, which may include histopathological evaluation, is recommended.

Diagnostic 93

Diagnostic Radiation Oncology Radiation Clinic 93

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman. please insert video here.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

OCTOBER 2, 2023

milla1cf Mon, 10/02/2023 - 13:00 October 2, 2023 — A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income countries may be treated effectively with fewer, but higher doses of radiation , a large new international study suggests.

Radiation 52

Radiation Radiation Oncology Public Health Diagnose 52

AuntMinnie

JANUARY 26, 2024

Conversely, FAPI radiotracers such as gallium-68 (Ga-68) FAPI have been developed that bind to fibroblast cells in the supportive tissue of tumors, and these PET tracers have shown significant promise for detecting disease in previous studies. PET/CT and MR images of a 72-year-old woman. (A) but presented no evidence for primary tumor.

Nuclear Medicine 122

Nuclear Medicine Imaging MRI Diagnostic 122

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

OCTOBER 5, 2023

Effective initial staging of prostate cancer, particularly with regards to the detection of metastatic disease, is critical to optimal clinical management of patients,” said Phillip H. Such information can help guide treatment selection and potentially avoid futile surgery for patients with high-risk disease.” “We

Diagnose 52

Diagnose Diagnostic Disease Radiation 52

Imaging Technology

NOVEMBER 20, 2023

milla1cf Mon, 11/20/2023 - 12:49 November 20, 2023 — The American Society for Radiation Oncology (ASTRO) issued a clinical guideline on partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ ( DCIS ).

Radiation Oncology 59

Radiation Oncology Clinic Radiation Disease 59

Imaging Technology

DECEMBER 1, 2023

milla1cf Fri, 12/01/2023 - 13:13 December 1, 2023 — The Radiation Oncology Program at Children’s Hospital Los Angeles is one of only a few in the country to care exclusively for children. The high-dose radiation may attract T-cells, which then go on to kill a much bigger area of the tumor.”

Radiation 102

Radiation Radiation Oncology Clinic Hospital 102

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology. Chang insists that BAMF Health is not a clinical company.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

MAY 2, 2024

One of the biggest challenges of oncology care is the complexity of the disease - both in the many varieties of cancer, and the disparate ways it can present in each individual patient [ii] - requiring diligence and personalization in diagnosis and treatment.

Healthcare 59

Healthcare Healthcare Radiation Oncology Radiation 59

Imaging Technology

MAY 15, 2023

milla1cf Mon, 05/15/2023 - 10:26 May 15, 2023 — GE HealthCare is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite) – that underscore the company’s commitment to enhancing the radiation oncology care pathway.

Radiation 94

Radiation Healthcare Healthcare Radiation Oncology 94

Imaging Technology

OCTOBER 3, 2023

These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting.

Radiation 81

Radiation Computed Tomography Radiation Oncology Magnetic Resonance Imaging 81

Imaging Technology

DECEMBER 27, 2023

You can target the proton beam in a highly specific way that results in virtually no damage to the surrounding healthy tissues,” said Arnab Chakravarti , MD, director of the proton therapy center and chair of the Department of Radiation Oncology at OSUCCC – James. Food and Drug Administration.

Radiation Oncology 94

Radiation Oncology Radiation X-ray Hospital 94

AuntMinnie

JANUARY 31, 2024

In data from a phase III clinical trial, the investigators found that gallium-68 (Ga-68) PSMA-11 PET initiated major management changes to salvage radiotherapy (RT) planning in 33% of patients – notably, a group for whom the technique was first approved in the U.S.

Radiation 107

Radiation Clinic Disease Radiation Oncology 107

AuntMinnie

DECEMBER 22, 2023

NK/T-cell lymphoma originates from mature T cells and NK cells; while the disease has a low incidence, it progresses rapidly and patients have low survival outcomes, the authors explained. Finally, after the PET/CT scan was done, the patient’s staging was changed from II to IV.

Diagnose 116

Diagnose Hospital Radiation Oncology Disease 116